QuadraMed to Showcase HIM and Smart Identity Management Solutions at AHIMA 2008 National Convention
National Conference Sponsor presents technology to transform quality care into positive financial outcomes
RESTON, Va.--(BUSINESS WIRE)--QuadraMed (NASDAQ:QDHC) announced today that it will showcase its Health Information Management (HIM) and Best in KLAS Smart Identity® Management solutions at the American Health Information Management Association (AHIMA) Conference & Exhibit (Booth #329) on Oct. 13-15 at the Washington State Convention Center in Seattle, Wash. QuadraMed is an AHIMA Leadership Circle participant and 2008 National Conference Sponsor.
QuadraMed will showcase its HIM solutions, including QuadraMed Abstracting, Inpatient and Outpatient Coding, Inpatient and Outpatient Compliance, Record Management, Correspondence Management, eSignature and Electronic Document Management. These solutions help organizations efficiently manage patient care, patient data access and revenue processes.
Additionally, QuadraMed will exhibit its award-winning Smart Identity® Management product suite, including QuadraMed Smart Identity® Exchange, SmartID®, SmartSwipe, Smart Merge®, SmartManager and MPISpy®. The solutions empower users with all the tools, information and professional support they need to accurately identify, correct and prevent the creation of duplicate patient records, providing the foundation for quality care and appropriate reimbursement.
“AHIMA is the premier conference at which to demonstrate how QuadraMed’s HIM and Smart Identity® Management solutions enable medical record professionals to capture, share and manage the information necessary to comply with complex coding regulations and drive better clinical and financial decision-making enterprise-wide,” said Keith Hagen, QuadraMed’s President and CEO.
Mary Bessinger, Product Consultant Manager, and Virginia Marcus, Product Manager, will present “National Hospital Quality Measures: HIM Role in Data Collection” on Tuesday, Oct. 14 at 3:30 p.m. EST.
Additional presentations will be conducted in the QuadraMed booth by QuadraMed clients and partners on topics such as best practices for implementation of ICD-10, how to prepare for CMS’ RAC initiative, review of 10 “reasonably preventable” hospital-acquired conditions, and an overview of the importance of Master Person Index (MPI) accuracy for enterprise interoperability. A complete list of QuadraMed presentations is available at the Company's booth during AHIMA, or at www.quadramed.com/ahima2008.
About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. QuadraMed provides real world solutions that help healthcare professionals deliver outstanding patient care efficiently and cost effectively. Behind the company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed’s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.